DGPR1008
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for DGPR1008, covering 2025-06-17 to 2026-02-17. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of PSMA-Targeted Fluorescent Contrast Agent DGPR1008 for Intraoperative Imaging in Robot-Assisted Radical Prostatectomy [Phase 2]